Antares Therapeutics
PrivateLast Round
Corporate Funding
Jun 24, 2026
Total Funding Raised
$177M
Momentum
Top 25%
of companies Caplight tracks
Company Overview
Antares Therapeutics operates in Healthcare & Life Sciences and is based in Boston, Massachusetts. Its latest recorded funding round was a Series A round in June 2025.
Antares Therapeutics is a biotechnology company that develops first-in-class precision medicines targeting previously undruggable proteins in oncology and other serious diseases.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Precision Medicine
Business Model
B2B
Customer Profile
Services & Consulting, Revenue Share
AI Layer
Application
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Antares Therapeutics Comparables
Compare Antares Therapeutics with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Frontier Medicines | 87% | |
| Nimbus Therapeutics | 83% | |
| Belharra Therapeutics | 83% |
For institutional investors. Book with your work email.
Antares Therapeutics Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Corporate Funding | Jun 24, 2026 | ||||
| Series A | Jun 10, 2025 |
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
Antares Therapeutics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Omega Funds | Series A |
| Cormorant Asset Management | Series A |
| Vida Ventures | Series A |
| Abingworth | Series A |
| BVF Partners L.P. | Series A |
| Atlas Venture | Series A |
| Willett Advisors | Series A |
For institutional investors. Book with your work email.
Market signals
Structured signals derived from secondary market and firmographic data.
- Aug 20, 2026
Monthly visitors increased 35% MoM, reaching 6.9K.
- Jul 26, 2026
Monthly visitors increased 57% MoM.
For institutional investors. Book with your work email.
Antares Therapeutics Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Antares Therapeutics's valuation, stock price, and market status.
Is Antares Therapeutics a public or private company?
Antares Therapeutics is a private company.
What is the current stock price of Antares Therapeutics?
Antares Therapeutics is a private company, so its shares have no public market price. Caplight tracks Antares Therapeutics's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Antares Therapeutics worth (valuation)?
Valuation information for Antares Therapeutics is not publicly available.
Can I buy Antares Therapeutics stock?
Antares Therapeutics shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Antares Therapeutics's last funding round?
Antares Therapeutics's most recent funding round was Corporate Funding on June 24, 2026.
Who are the main investors in Antares Therapeutics?
Key investors in Antares Therapeutics include Omega Funds, Cormorant Asset Management, BVF Partners L.P., Atlas Venture, Lightspeed Venture Partners.
Will Antares Therapeutics IPO soon?
No public IPO plans have been announced for Antares Therapeutics.
How can I track Antares Therapeutics secondary market activity?
Caplight tracks bids, offers, and trades in Antares Therapeutics's shares on secondary markets.